Most Recent Annual Report
2019 Annual Report and Form 10K
Athersys, Inc. has reached its limit for free report views.
You can request a free hardcopy of this report mailed to you by clicking the button below.
Athersys, Inc.
Order Free Hardcopy
About Athersys, Inc.
51-200 Employees
Based in Cleveland, Ohio
Athersys is an international biotechnology company engaged in the development of therapeutic products designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived “off-the-shelf” stem cell product, initially for disease indications in the neurological, cardiovascular, and inflammatory and immune disease areas, and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance MultiStem cell therapy toward commercialization.
- Ticker:
- ATHX
- Exchange:
- NASDAQ (See More NASDAQ Companies)
- Industry:
- Biotechnology (See More Biotechnology Companies)
- Sector:
- Healthcare (See More Healthcare Companies)
